ACE2 activation confers endothelial protection and attenuates neointimal lesions in prevention of severe pulmonary arterial hypertension in rats

Lung

Volumn 191, Issue 4, 2013, Pages 327-336

  Li, Gang ^a   Liu, Yinglong ^a   Zhu, Yaobin ^a   Liu, Aijun ^a   Xu, Yulin ^a   Li, Xiaofeng ^a   Li, Zhiqiang ^a   Su, Junwu ^a   Sun, Lizhong ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Angiotensin; Endothelial dysfunction; Pulmonary arterial hypertension; Remodeling

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN II [3-8]; ANGIOTENSIN III; ANGIOTENSIN V; ANGIOTENSIN VI; ANGIOTENSIN VII; ANGIOTENSIN[1-7][7 DEXTRO ALANINE]; MONOCROTALINE; RESORCINOL DERIVATIVE; RESORCINOLNAPHTHALEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVATION; HEART RIGHT VENTRICLE HYPERTROPHY; LUNG ARTERY PRESSURE; LUNG HEMODYNAMICS; LUNG RESECTION; MALE; NEOINTIMA; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VASODILATATION;

EID: 84880778204     PISSN: 03412040     EISSN: 14321750     Source Type: Journal    
DOI: 10.1007/s00408-013-9470-8     Document Type: Article

References (33)

1. Fukumoto Y, Shimokawa H (2011) Recent progress in the management of pulmonary hypertension. Circ J 75(8):1801-1810
2. Nicod LP (2007) The endothelium and genetics in pulmonary arterial hypertension. Swiss Med Wkly 137:437-442
3. Shenoy V, Qi Y, Katovich MJ, et al. (2011) ACE2, a promising therapeutic target for pulmonary hypertension. Curr Opin Pharmacol 11:150-155
4. Marshall RP (2003) The pulmonary rennin-angiotensin system. Curr Pharm Des 9:715-722
5. Bradford CN, Ely DR, Raizada MK (2010) Targeting the vasoprotective axis of the renin-angiotensin system: a novel strategic approach to pulmonary hypertensive therapy. Curr Hypertens Rep 12:212-219
6. Imai Y, Kuba K, Ohto-Nakanishi T, et al. (2010) Angiotensin-converting enzyme 2 (ACE2) in disease pathogenesis. Circ J 74(3):405-410
7. Yamazato Y, Ferreira AJ, Hong KH, et al. (2009) Prevention of pulmonary hypertension by angiotensin-converting enzyme 2 gene transfer. Hypertension 54:365-371
8. Ferreira AJ, Shenoy V, Yamazato Y, et al. (2009) Evidence for angiotensin-converting enzyme 2 as a therapeutic target for the prevention of pulmonary hypertension. Am J Respir Crit Care Med 179:1048-1054
9. Hernández Prada JA, Ferreira AJ, Katovich MJ, Shenoy V, et al. (2008) Structure-based identification of small-molecule angiotensin-converting enzyme 2 activators as novel antihypertensive agents. Hypertension 51:1312-1317
10. Li G, Xu YL, Ling F, et al. (2012) Angiotensin-converting enzyme 2 activation protects against pulmonary arterial hypertension through improving early endothelial function and mediating cytokines levels. Chin Med J (Engl) 125(8):1381-1388
11. Okada K, Tanaka Y, Bernstein M, et al. (1997) Pulmonary hemodynamics modify the rat pulmonary artery response to injury. A neointimal model of pulmonary hypertension. Am J Pathol 151:1019-1025
12. Schermuly RT, Dony E, Ghofrani HA, et al. (2005) Reversal of experimental pulmonary hypertension by PDGF inhibition. J Clin Invest 115:2811-2821
13. Hyman AL, Hao Q, Tower A, et al. (1998) Novel catheterization technique for the in vivo measurement of pulmonary vascular responses in rats. Am J Physiol 274:H1218-H1229
14. Nishimura T, Vaszar LT, Faul JL, et al. (2003) Simvastatin rescues rats from fatal pulmonary hypertension by inducing apoptosis of neointimal smooth muscle cells. Circulation 108:1640-1645
15. Gembardt F, Sterner-Kock A, Imboden H, Spalteholz M, et al. (2005) Organ-specific distribution of ACE2 mRNA and correlating peptidase activity in rodents. Peptides 26:1270-1277
16. Zhong JC, Yu XY, Lin QX, et al. (2008) Enhanced angiotensin converting enzyme 2 regulates the insulin/Akt signalling pathway by blockade of macrophage migration inhibitory factor expression. Br J Pharmacol 153(1):66-74
17. Lovren F, Pan Y, Quan A, et al. (2008) Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis. Am J Physiol Heart Circ Physiol 295:H1377-H1384
18. Sampaio WO, Souza dos Santos RA, Faria-Silva R, da Mata Machado LT, et al. (2007) Angiotensin-(1-7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways. Hypertension 49(1):185-192
19. Muthalif MM, Benter IF, Uddin MR, et al. (1998) Signal transduction mechanisms involved in angiotensin-(1-7)-stimulated arachidonic acid release and prostanoid synthesis in rabbit aortic smooth muscle cells. J Pharmacol Exp Ther 284(1):388-398
20. Zhang C, Zhao YX, Zhang YH, et al. (2010) Angiotensin-converting enzyme 2 attenuates atherosclerotic lesions by targeting vascular cells. Proc Natl Acad Sci USA 107:15886-15891
21. Rentzsch B, Todiras M, Iliescu R, et al. (2008) Transgenic angiotensin-converting enzyme 2 overexpression in vessels of SHRSP rats reduces blood pressure and improves endothelial function. Hypertension 52:967-973
22. Hacking WJ, VanBavel E, Spaan JA (1996) Shear stress is not sufficient to control growth of vascular networks: a model study. Am J Physiol 270:H364-H375
23. Pasterkamp G, Galis ZS, de Kleijn DP (2004) Expansive arterial remodeling: location, location, location. Arterioscler Thromb Vasc Biol 24:650-657
24. Shenoy V, Ferreira AJ, Qi Y, et al. (2010) The angiotensin-converting enzyme 2/angiogenesis-(1-7)/Mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension. Am J Respir Crit Care Med 182:1065-1072
25. Huang H, Zhang P, Wang Z, et al. (2011) Activation of endothelin-1 receptor signaling pathways is associated with neointima formation, neoangiogenesis and irreversible pulmonary artery hypertension in patients with congenital heart disease. Circ J 75(6):1463-1471
26. Curcio A, Torella D, Indolfi C (2011) Mechanisms of smooth muscle cell proliferation and endothelial regeneration after vascular injury and stenting: approach to therapy. Circ J 75(6):1287-1296
27. Hayashi N, Yamamoto K, Ohishi M, et al. (2010) The counterregulating role of ACE2 and ACE2-mediated angiotensin 1-7 signaling against angiotensin II stimulation in vascular cells. Hypertens Res 33:1182-1185
28. Jin XQ, Lu ZQ, Lin X (2011) Effect of ACE2 gene transfection on the proliferation of vascular smooth muscle cells in rats. Zhonghua Yi Xue Za Zhi 91:125-128
29. Sampaio WO, Henrique de Castro C, et al. (2007) Angiotensin-(1-7) counterregulates angiotensin II signaling in human endothelial cells. Hypertension 50:1093-1098
30. Igase M, Kohara K, Nagai T, et al. (2008) Increased expression of angiotensin converting enzyme 2 in conjunction with reduction of neointima by angiotensin II type 1 receptor blockade. Hypertens Res 31:553-559
31. Ferreira AJ, Shenoy V, Qi Y, Fraga-Silva RA, et al. (2011) Angiotensin-converting enzyme 2 activation protects against hypertension-induced cardiac fibrosis involving extracellular signal-regulated kinases. Exp Physiol 96(3):287-294
32. Xie X, Chen J, Wang X, et al. (2006) Age- and gender-related difference of ACE2 expression in rat lung. Life Sci 78(19):2166-2171
33. Vickers C, Hales P, Kaushik V, et al. (2002) Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem 277:14838-14843